Predialysis education: some cliffhangers. Transplantation Renal Replacement Therapy Hemodialysis Peritoneal Dialysis Options for End-Stage Renal Disease.

Slides:



Advertisements
Similar presentations
THE CHOICE OF DIALYSIS ACCES CONTROVERSY AND EVIDENCE
Advertisements

Critical Thinking and Decision Making Arnuparp Lekhakula Faculty of Medicine Prince of Songkla University Hat Yai, Songkhla.
Right Care for Patients The National Shared Decision Making Programme.
Large Scale Implementation of Patient Decision Aids in an Integrated Group Practice: the Group Health Experience David Arterburn, MD, MPH Group Health.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
Treatment Options for End Stage Kidney Disease Dr Vipula De Silva.
Renal Process Mapping from Renal Stakeholder Event Emergency Diagnostic tests ordered Secondary Referral General Practitioner General Practitioner Tertiary.
Renal Replacement Therapy: What the PCP Needs to Know.
CAPD eBook: Evaluating Multimedia Application for Continuous Ambulatory Peritoneal Dialysis (CAPD) Users Presenter: Mohammad Hafiz Ismail Arifah Fasha.
A E UROPEAN R ENAL B EST P RACTICE (ERBP) POSITION STATEMENT ON THE K IDNEY D ISEASE I MPROVING G LOBAL O UTCOMES (KDIGO) C LINICAL P RACTICE G UIDELINES.
Cheaper Kidney Care Vs. Redesigning kidney services to improve patient choice, shared decision making and deliver NHS costing savings.
Zuragen® Lock (an investigational device)
What is the Role of Peritoneal Dialysis in Optimising ESRD Patient Outcomes?
« Renal transplantation is the most appropriate treatment choice for the patients if end stage renal failure develops, preemptive transplantation is the.
Kidney Diseases Prevention. Overview The mortality rate of Nephritis, Nephrotic Syndrome, and Nephrosis (18.15 per 100,000 population) marching the 7th.
CKD Conservative care and preparation for dialysis UK Renal Registry 2013 Annual Audit Meeting Dr Anirudh Rao Registrar, UK Renal Registry.
Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
Exploring centre variation in RRT provision Dr Clare Castledine UKRR clinical fellow.
Peritoneal Dialysis for Elderly Patients: A Review Source: Tesar V. Peritoneal dialysis in the elderly—is its underutilization justified? Nephrol Dial.
Perioperative fasting guideline Getting it into practice Getting started.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Development of an interactive patient information web site - the importance of consumer involvement Peter Rutherford, Paul Forte, Tom Bowen, Rory Matthews.
Hemodialysis. Hemodialysis (also haemodialysis) is a method for removing waste products such as potassium and urea, as well as free water from the blood.
James Heaf Herlev Hospital University of Copenhagen
Renal Medicine David Johnson Princess Alexandra Hospital Brisbane, Australia A Comparison of APD vs CAPD on Patient Outcomes A Comparison of APD vs CAPD.
KIMBERLEY RENAL SUPPORT SERVICE (KRSS) The Role of Predialysis Coordinator.
Principles and Techniques of Dialysis. Introduction 2 basic techniques – haemo or peritoneal Several refinements within these Haemo –Dialysis –Filtration.
Advanced CKD Study Daniel Ford UKRR Annual Audit Meeting June 2009.
Competencies Timon W. van Haeften, MD, PhD Master-coordinator Utrecht.
Elizabeth Stallworthy Nephrologist August 2015
Section 5: Configuration of healthcare to manage CKD.
Dialysis: outcome and complications. Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo.
Al wakeel J, Bayoumi M, Al Ghonaim M, Al Harbi A, Al Swaida A, Mashraqy A.
 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
Conceptualizing Illness Experience and Perceived Quality of Life of Cree from the Mushkegowuk Territory with End-Stage Kidney Disease Relocated to an Urban.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
’10 slides on peritoneal dialysis in older CKD patients’
Self Care Instructions Exercise regularly Monitor your blood pressure Eat a healthful diet.
USRDS 1999 Point Prevalence Counts by Modality, Data Source, and Year, Count (1000s) Year Center Hemo Functioning Transplant PD Home Hemo Facility.
Advance Care Planning in Haemodialysis patients-Staff engagement versus patient wishes Susan Heatley Renal Matron.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
SELF CARE HAEMODIALYSIS PROGRAM ME.  Self Care project outline Haemodialysis patient education programme, in managing renal failure and dialysis procedure.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
NIPEC Annual Conference Professional Standards Enhancing Person-Centred Care Assisted Automated Peritoneal Dialysis(aAPD) Susie Mawhinney PD Nurse BCH.
Kidney disease burden and available Renal transplantation and Dialysis services in India Dr. Sham Sunder.
Renal Transplantation at Shrewsbury and Telford NHS Trust. Sue Dean – Transplant Nurse. Suresh Ramadoss – Nephrologist and Transplant Lead. 9/7/15.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
World Kidney Day 2016: Kidney Disease & Children
Reference: Covic A, Bammens B, Lobbedez T, et al
First-year death rates by modality figure 8
Prevalence (pmp) of Renal Replacement Therapy
Neethi Reddy Bathula HCI4H: Thursday 9 February 2016
The CANUSA Trial Reference
CHAPTER 5 Paediatric Renal Replacement Therapy
Iron Deficiency Anemia
Study sample selection process.
Volume 64, Pages S3-S12 (December 2003)
Iron Deficiency Anemia
The risk of hospitalization and modality failure with home dialysis
Section 5: Configuration of healthcare to manage CKD
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Volume 73, Issue 4, Pages (February 2008)
Volume 80, Issue 9, Pages (November 2011)
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
Risk factor Treatment GFR at baseline GFR at 5 years p Cadaveric donor
Volume 73, Pages S72-S75 (April 2008)
Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home.
New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.
Dialysis limitations. Dialysis limitations. (A) Recent data from observational studies and randomized, clinical trials indicate significant limitations.
Presentation transcript:

Predialysis education: some cliffhangers

Transplantation Renal Replacement Therapy Hemodialysis Peritoneal Dialysis Options for End-Stage Renal Disease Patients

Integrated care 2010 Follow up Before dialysis Hemodialysis In centre dialysis Satellite Dialysis home hemo Nocturnal dialysis Daily dialysis Creatinine Clearance (ml/min) Start of dialysis Peritoneal dialysis Transplantation Cadaveric living donor “Old for old” PD APD CAPD Assisted PD

The Kidney Early Evaluation Program Tamura et al, KI, 2013

What modality of dialysis should I choose? Dialysis modality selection: Clinical advice from the European Renal Best Practice (ERBP) Advisory Board

What modality of dialysis should I choose? Dialysis modality selection: Clinical advice from the European Renal Best Practice (ERBP) Advisory Board

What modality of dialysis should I choose? Dialysis modality selection: Clinical advice from the European Renal Best Practice (ERBP) Advisory Board

P ersonalised D ialysis –“informed patient choice” –Pre dialysis programs

Barriers at the provider level?

Odds of receiving PD as first line treatment Komenda et al, submitted

Hingwala et al, NDT, 2013 Patient survival

Hingwala et al, NDT, 2013 Technique survival

Patient perspectives on informed decision- making surrounding dialysis initiation Song et al, NDT, 2013

Sources of patient information Ceapir survey, Van Biesen et al, submitted

Sources of patient information Ceapir survey, Van Biesen et al, submitted Patients that were involved with decision making were much more likely to be satisfied with their treatment (OR 3.13 (95% CI )

Morton et al, BMJ, 2009

Patient Information: Predialysis 1.Patients do not recall having been informed at all 2.Patients are informed “too late” i.e. in a state when they are uraemic, desperate, depressed by their diagnosis…. Language too difficult Irrelevant information Too much information 3.Their is a “communication problem” between medical staff and patients on which topics/factors to value Empathic listening Motivational interviewing 4.Patients tend to make heuristic, not objective decisions Danger of exposing them to other patients

Shared decison making

1.Making the options clear 2.Help the patient with making an informed choice 1.Value Clarification 2.Elicit patient preferences 3.Avoid bias by your own beliefs and values 4.Suggest solutions that fit these values and preferences 5.Facilitate decision making

Shared decison making 1.Making the options clear 2.Help the patient with making an informed choice 1.Elicit patient preferences 2.Suggest solutions that fit these preferences 3.Facilitate decision making Inform

(but the information does not exist)

(but the information does not exist) Is APD better than CAPD?

Relative risk CAPD vs APD Mehrotra et al, KI 2009

Survival CAPD vs APD Michels et al, cJASN, 2009

Survival CAPD vs APD Badve et al, KI 2008

Survival fast transporters APD vs CAPD Johnson et al, NDT, 2010 APD survival superior in fast transporters, but CAPD better in slow transporters

Incident patient vs 90-day Analyses Quinn JASN 22:

Probabilityambiguity complexity CONTEXT

Shared decison making 1.Making the options clear 2.Help the patient with making an informed choice 1.Value Clarification 2.Elicit patient preferences 3.Suggest solutions that fit these preferences 4.Facilitate decision making Inform Deliberate

Morton et al, BMJ, 2009

Anchoring (+Halo effect) Attribution Availability

Nephrology fellow Nephrologist Head nurse operating theatre anesthesist nutrition Supervisor PD Head nurse Nephrology Surgeon Team management!!!

Approaches to Value Clarification/Preference Elicitation process: interactive eg using sliding scales, ordering cards etc 1.assumptions: a.working "interactive" provides the patient with insight in his/her preference b.the patient has to make his preference clear to the other person 2.can be indirect (ask questions outside the question at end to obtain general preference) or direct 3. always be careful to avoid decision regret and increased anxiety in patients 4. always be careful to avoid "unbalanced" "coloured" phrasings non interactive eg video, dvd, booklets, patient stories, case scenarios: 1.this can be dangerous as they provide information in a linear fashion, and do not allow the "PE" step, which has to be made by the patient himself; 2.underlying assumption: patient will take the VC step while going through the information and will do the PE step later

Shared decison making 1.Making the options clear 2.Help the patient with making an informed choice 1.Elicit patient preferences 2.Suggest solutions that fit these preferences 3.Facilitate decision making Inform Deliberate Decide

Yodda: inform Available on:

Yodda: deliberate Haemodialysis Peritoneal Dialysis

Yodda: deliberate

Yodda: helping in decision

“Shared Decision Making”